Jin-Feng Ning

机构：Fudan University

发表论文 5 篇 · 总被引 41 次 · h-index 4

代表论文

• Discovery of First-in-Class TAK1–MKK3 Protein–Protein Interaction (PPI) Inhibitor ( R )-STU104 for the Treatment of Ulcerative Colitis through Modulating TNF-α Production (2022 · Journal of Medicinal Chemistry · 被引 12)
• Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity (2020 · European Journal of Medicinal Chemistry · 被引 12)
• Navigating into the binding pockets of the HER family protein kinases: discovery of novel EGFR inhibitor as antitumor agent (2015 · Drug Design Development and Therapy · 被引 11)
• Sulfoxide-mediated approach to flavones through one-pot Knoevenagel condensation/oxa-Michael addition/sulfoxide elimination process of β-(o-hydroxyaryl)-ketosulfone with arylaldehydes (2022 · Tetrahedron Letters · 被引 5)
• Discovery ofNovel Selective Estrogen Receptor β(SERβ) Agonist ( S )-STO021 as an AntiosteoporosisCandidate with Dual Functions of Inhibiting Osteoclastogenesis andActivating Osteoblastogenesis (2025 · Journal of Medicinal Chemistry · 被引 1)